{"id":"chlorcyclizine","rwe":[{"pmid":"39824305","year":"2025","title":"The Histamine Pathway is a Target to Treat Hepatic Experimental Erythropoietic Protoporphyria.","finding":"","journal":"Cellular and molecular gastroenterology and hepatology","studyType":"Clinical Study"},{"pmid":"38632089","year":"2024","title":"Comparison of Classical and Green RPLC Methods in the Determination of pK(a) Values of Some Piperazine Group Antihistamines.","finding":"","journal":"Chemistry (Weinheim an der Bergstrasse, Germany)","studyType":"Clinical Study"},{"pmid":"38576224","year":"2024","title":"Chiral resolution of cationic piperazine derivatives by capillary electrophoresis using sulfated β-cyclodextrin.","finding":"","journal":"Electrophoresis","studyType":"Clinical Study"},{"pmid":"38313503","year":"2024","title":"Electrochemical HPLC Determination of Piperazine Antihistamine Drugs Employing a Spark-Generated Nickel Oxide Nanoparticle-Modified Carbon Fiber Microelectrode.","finding":"","journal":"ACS omega","studyType":"Clinical Study"},{"pmid":"37424359","year":"2023","title":"Inhibitors Targeting Hepatitis C Virus (HCV) Entry.","finding":"","journal":"Mini reviews in medicinal chemistry","studyType":"Clinical Study"}],"_fda":{"id":"4041d3f9-d1cb-0931-e063-6394a90a82de","set_id":"ccedbc38-2479-4c35-9f86-a9f29bcfab3f","openfda":{"unii":["NPB7A7874U","6V9V2RYJ8N"],"route":["ORAL"],"rxcui":["1235861","1236716"],"spl_id":["4041d3f9-d1cb-0931-e063-6394a90a82de"],"brand_name":["STAHIST AD"],"spl_set_id":["ccedbc38-2479-4c35-9f86-a9f29bcfab3f"],"package_ndc":["58407-625-30","58407-625-01","58407-625-06"],"product_ndc":["58407-625"],"generic_name":["CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE"],"product_type":["HUMAN OTC DRUG"],"substance_name":["CHLORCYCLIZINE HYDROCHLORIDE","PSEUDOEPHEDRINE HYDROCHLORIDE"],"manufacturer_name":["Magna Pharmaceuticals, Inc."],"application_number":["M012"],"is_original_packager":[true]},"purpose":["Active Ingredients (in each immediate-release tablet) Purpose Chlorcyclizine HCl 25 mg Antihistamine Pseudoephedrine HCl 60 mg Nasal Decongestant"],"version":"8","stop_use":["Stop use and ask a doctor if nervousness, dizziness or sleeplessness occur symptoms do not improve within 7 days or are accompanied by fever new symptoms occur"],"warnings":["Warnings Do not exceed recommended dosage. Do not use this product If you are taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for two weeks after stopping the MAOI drug. If you do not know if your prescription drug contains MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma heart disease high blood pressure thyroid disease diabetes melitus difficulty in urination due to enlargement of the prostate gland Ask a doctor before use if you are taking sedatives or tranquilizers When using this product excitability may occur, especially in children may cause drowsiness alcohol, sedatives and tranquilizers may increase drowsiness effect avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery Stop use and ask a doctor if nervousness, dizziness or sleeplessness occur symptoms do not improve within 7 days or are accompanied by fever new symptoms occur If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of accidental overdose, seek professional help or contact a Poison Control Center immediately."],"questions":["Questions or Comments? Call 1-888-206-5525 • www.magnaweb.com"],"ask_doctor":["Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma heart disease high blood pressure thyroid disease diabetes melitus difficulty in urination due to enlargement of the prostate gland"],"do_not_use":["Do not use this product If you are taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for two weeks after stopping the MAOI drug. If you do not know if your prescription drug contains MAOI, ask a doctor or pharmacist before taking this product."],"when_using":["When using this product excitability may occur, especially in children may cause drowsiness alcohol, sedatives and tranquilizers may increase drowsiness effect avoid alcoholic beverages use caution when driving a motor vehicle or operating machinery"],"purpose_table":["
Active Ingredients (in each immediate-release tablet) Purpose
Chlorcyclizine HCl 25 mgAntihistamine
Pseudoephedrine HCl 60 mgNasal Decongestant
"],"effective_time":"20251003","active_ingredient":["Active Ingredients (in each immediate-release tablet) Purpose Chlorcyclizine HCl 25 mg Antihistamine Pseudoephedrine HCl 60 mg Nasal Decongestant"],"inactive_ingredient":["Inactive ingredients Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate"],"indications_and_usage":["Uses temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: runny nose sneezing itching of the nose or throat itchy, watery eyes nasal congestion reduces swelling of nasal passages"],"active_ingredient_table":["
Active Ingredients (in each immediate-release tablet) Purpose
Chlorcyclizine HCl 25 mgAntihistamine
Pseudoephedrine HCl 60 mgNasal Decongestant
"],"ask_doctor_or_pharmacist":["Ask a doctor before use if you are taking sedatives or tranquilizers"],"spl_unclassified_section":["Drug Facts","Rev. 10/11"],"dosage_and_administration":["Directions Do not exceed recommended dosage. Adults and children 12 years of age and over: 1 tablet by mouth every 6-8 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor Children 6 to under 12 years of age: ½ tablet by mouth every 6-8 hours, not to exceed 1½ tablets in 24 hours, or as directed by a doctor Children under 6 years of age Consult a doctor"],"spl_product_data_elements":["STAHIST AD CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE MICROCRYSTALLINE CELLULOSE MAGNESIUM STEARATE SODIUM STARCH GLYCOLATE TYPE A POTATO CHLORCYCLIZINE HYDROCHLORIDE CHLORCYCLIZINE PSEUDOEPHEDRINE HYDROCHLORIDE PSEUDOEPHEDRINE M625"],"pregnancy_or_breast_feeding":["If pregnant or breast-feeding, ask a health professional before use."],"keep_out_of_reach_of_children":["Keep out of reach of children. In case of accidental overdose, seek professional help or contact a Poison Control Center immediately."],"dosage_and_administration_table":["
Adults and children 12 years of age and over:1 tablet by mouth every 6-8 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor
Children 6 to under 12 years of age:½ tablet by mouth every 6-8 hours, not to exceed 1½ tablets in 24 hours, or as directed by a doctor
Children under 6 years of ageConsult a doctor
"],"package_label_principal_display_panel":["Add image transcription here... Stahist AD Principal Display Panel"]},"tags":[{"label":"chlorcyclizine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Apoptosis regulator Bcl-2","category":"target"},{"label":"BCL2","category":"gene"},{"label":"R06AE04","category":"atc"},{"label":"Oral","category":"route"},{"label":"Liquid","category":"form"},{"label":"Tablet","category":"form"},{"label":"Active","category":"status"},{"label":"Allergic conjunctivitis","category":"indication"},{"label":"Allergic rhinitis","category":"indication"},{"label":"Common cold","category":"indication"},{"label":"Cough","category":"indication"},{"label":"Nasal congestion","category":"indication"},{"label":"Nasal discharge","category":"indication"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"SINUSITIS","source":"FDA FAERS","actionTaken":"6 reports"},{"date":"","signal":"INFLUENZA","source":"FDA FAERS","actionTaken":"5 reports"},{"date":"","signal":"BLOOD PRESSURE INCREASED","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"GASTROENTERITIS VIRAL","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"PHARYNGITIS","source":"FDA FAERS","actionTaken":"4 reports"},{"date":"","signal":"BREAST CANCER FEMALE","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"BRONCHITIS","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"COVID-19","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"INSOMNIA","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"3 reports"}],"contraindications":["Acidosis","Acute abdominal pain","Acute exacerbation of asthma","Acute hepatitis","Acute pancreatitis","Adrenal cortical hypofunction","Angle-closure glaucoma","Arterial thrombosis","Arteriosclerotic vascular disease","Atrophoderma","Benign intracranial hypertension","Benign prostatic hyperplasia","Bladder outflow obstruction","Bradycardia","Central nervous system depression","Chronic disease of respiratory system","Chronic heart failure","Chronic idiopathic constipation","Conduction disorder of the heart","Coronary arteriosclerosis","Decreased respiratory function","Dependent drug abuse","Diabetes mellitus","Disease of liver","Disorder of coronary artery"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CHLORCYCLIZINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:19:51.140393+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:19:56.720829+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CHLORCYCLIZINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:19:57.199831+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:19:49.866495+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:19:49.866535+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:19:58.753898+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL22150/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:19:57.977459+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M012","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:19:49.866539+00:00"}},"allNames":"perazyl","offLabel":[],"synonyms":["chlorcyclizine","chlorcycline","chlorocycline","perazyl","chlorcyclizine hydrochloride","chlorcyclizine HCl"],"timeline":[],"approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Perazyl","ecosystem":[{"indication":"Allergic conjunctivitis","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alcaftadine","slug":"alcaftadine","company":"Allergan"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null},{"indication":"Allergic rhinitis","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"astemizole","slug":"astemizole","company":""}],"globalPrevalence":null},{"indication":"Common cold","otherDrugs":[{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"azatadine","slug":"azatadine","company":""}],"globalPrevalence":null},{"indication":"Cough","otherDrugs":[{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"benzocaine","slug":"benzocaine","company":""},{"name":"benzonatate","slug":"benzonatate","company":"Pfizer"},{"name":"bromazine","slug":"bromazine","company":"Forest Labs"}],"globalPrevalence":null},{"indication":"Nasal congestion","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":null},{"indication":"Nasal discharge","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"antazoline","slug":"antazoline","company":"Novartis"}],"globalPrevalence":30000000},{"indication":"Seasonal allergic rhinitis","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"azatadine","slug":"azatadine","company":""},{"name":"azelastine","slug":"azelastine","company":"Meda Pharms"},{"name":"brompheniramine","slug":"brompheniramine","company":""}],"globalPrevalence":null},{"indication":"Sneezing","otherDrugs":[{"name":"acrivastine","slug":"acrivastine","company":"Auxilium Pharms Inc"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"astemizole","slug":"astemizole","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Apoptosis regulator Bcl-2","novelty":"First-in-class","targets":[{"gene":"BCL2","source":"DrugCentral","target":"Apoptosis regulator Bcl-2","protein":"Apoptosis regulator Bcl-2"}],"modality":"Small Molecule","drugClass":"chlorcyclizine","explanation":"","oneSentence":"","technicalDetail":"Perazyl acts as a Bcl-2 inhibitor, specifically targeting the anti-apoptotic function of Bcl-2, which is involved in the regulation of apoptosis and cell survival pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/593","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CHLORCYCLIZINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CHLORCYCLIZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:33:13.138030","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:20:00.129772+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"buclizine","drugSlug":"buclizine","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"cyclizine","drugSlug":"cyclizine","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"meclozine","drugSlug":"meclozine","fdaApproval":"1957-02-14","relationship":"same-class"},{"drugName":"cetirizine","drugSlug":"cetirizine","fdaApproval":"1995-12-08","patentExpiry":"Sep 15, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"levocetirizine","drugSlug":"levocetirizine","fdaApproval":"2007-05-25","patentExpiry":"Oct 16, 2027","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"chlorcyclizine","indications":{"approved":[{"name":"Allergic conjunctivitis","source":"DrugCentral","snomedId":473460002,"regulator":"FDA","eligibility":"Adults and children 6 years and older"},{"name":"Allergic rhinitis","source":"DrugCentral","snomedId":61582004,"regulator":"FDA","eligibility":"Adults and children 6 years and older"},{"name":"Common cold","source":"DrugCentral","snomedId":82272006,"regulator":"FDA","eligibility":"Not specified"},{"name":"Cough","source":"DrugCentral","snomedId":49727002,"regulator":"FDA","eligibility":"Not specified"},{"name":"Nasal congestion","source":"DrugCentral","snomedId":68235000,"regulator":"FDA","eligibility":"Not specified"},{"name":"Nasal discharge","source":"DrugCentral","snomedId":64531003,"regulator":"FDA","eligibility":"Not specified","usPrevalence":null,"globalPrevalence":30000000,"prevalenceMethod":"curated","prevalenceSource":"Influenza Other Respir Viruses, 2023 (PMID:36824394)"},{"name":"Seasonal allergic rhinitis","source":"DrugCentral","snomedId":367498001,"regulator":"FDA","eligibility":"Adults and children 6 years and older"},{"name":"Sneezing","source":"DrugCentral","snomedId":76067001,"regulator":"FDA","eligibility":"Not specified"},{"name":"Vasomotor rhinitis","source":"DrugCentral","snomedId":8229003,"regulator":"FDA","eligibility":"Not specified"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"buclizine","brandName":"buclizine","genericName":"buclizine","approvalYear":"","relationship":"same-class"},{"drugId":"cyclizine","brandName":"cyclizine","genericName":"cyclizine","approvalYear":"","relationship":"same-class"},{"drugId":"meclozine","brandName":"meclozine","genericName":"meclozine","approvalYear":"1957","relationship":"same-class"},{"drugId":"cetirizine","brandName":"cetirizine","genericName":"cetirizine","approvalYear":"1995","relationship":"same-class"},{"drugId":"levocetirizine","brandName":"levocetirizine","genericName":"levocetirizine","approvalYear":"2007","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT02118012","phase":"PHASE1,PHASE2","title":"Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-03-20","conditions":["Chronic Hepatitis C"],"enrollment":24,"completionDate":"2016-09-20"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Liquid, Tablet","formulations":[{"form":"LIQUID","route":"ORAL","productName":"biclora"},{"form":"TABLET","route":"ORAL","productName":"AHIST"},{"form":"TABLET","route":"ORAL","productName":"STAHIST AD"},{"form":"TABLET, CHEWABLE","route":"ORAL","productName":"BonineKids"}]},"crossReferences":{"NUI":"N0000178900","MMSL":"11602","NDDF":"003398","UNII":"M26C4IP44P","VUID":"4019672","CHEBI":"CHEBI:94402","VANDF":"4018770","INN_ID":"1301","RXNORM":"2354","UMLSCUI":"C0008183","chemblId":"CHEMBL22150","ChEMBL_ID":"CHEMBL22150","DRUGBANK_ID":"DB08936","PUBCHEM_CID":"2710","SECONDARY_CAS_RN":"14362-31-3","MESH_SUPPLEMENTAL_RECORD_UI":"C084597"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":135,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"R06AE04","allCodes":["R06AE04"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025","pmid":"39824305","title":"The Histamine Pathway is a Target to Treat Hepatic Experimental Erythropoietic Protoporphyria.","journal":"Cellular and molecular gastroenterology and hepatology"},{"date":"2024 Jun 17","pmid":"38632089","title":"Comparison of Classical and Green RPLC Methods in the Determination of pK(a) Values of Some Piperazine Group Antihistamines.","journal":"Chemistry (Weinheim an der Bergstrasse, Germany)"},{"date":"2024 Sep","pmid":"38576224","title":"Chiral resolution of cationic piperazine derivatives by capillary electrophoresis using sulfated β-cyclodextrin.","journal":"Electrophoresis"},{"date":"2024 Jan 30","pmid":"38313503","title":"Electrochemical HPLC Determination of Piperazine Antihistamine Drugs Employing a Spark-Generated Nickel Oxide Nanoparticle-Modified Carbon Fiber Microelectrode.","journal":"ACS omega"},{"date":"2023","pmid":"37424359","title":"Inhibitors Targeting Hepatitis C Virus (HCV) Entry.","journal":"Mini reviews in medicinal chemistry"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Perazyl is a small molecule with the synonyms ALERGICIDE, CHLORCYCLIZINE, and others.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:20:00.129772+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}